Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nimotuzumab

EU orphan designation number: EU/3/08/550   
Active ingredient: Nimotuzumab
Indication: Treatment of pancreatic cancer
Sponsor: Oncoscience AG
Osterbrooksweg 59, 22869 Schenefeld, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/06/2008 Orphan designation EMEA/OD/006/08 (2008)2538 of 03/06/2008
18/08/2016 Change of name and/or address of sponsor